The MDIC project “A novel method for incorporation of PCOR in clinical trial design” developed and tested a method for incorporating patient preference information as an explicit means to set significance levels in clinical trial design. While the pilot focused on a specific disease state, Parkinson’s disease, the method may be generalizable to other diseases and has the potential to remove barriers to therapy access by giving patients a pathway to breakthrough, lifesaving technologies based, in part, on their risk tolerance.
Join MDIC, along with our collaborators CDRH, MIT, RTI Health Solutions and the Michael J. Fox Foundation for Parkinson’s Research, on May 18, 2018, at the Westin Arlington Gateway, as we share the results of this initiative and explore the implications of this novel method to incorporate patient preferences into the design of medical device clinical trials.
Learn more about the project at: http://mdic.org/spi/pcor
Additional agenda details will be posted on our web site: http://mdic.org/spi/pcor/workshop/
Friday, May. 1812:30 pm - 9:00 pm